Toll-like receptor (TLR) can activate dendritic cells (DC) through common signaling pathways requiring a cytoplasmic adapter, MyD88. However, the signaling is differentially regulated among TLR family members. TLR4 can activate MyD88-de®cient bone marrow-derived DC (BMDC), and lead to induction of IFN-inducible genes and up-regulation of co-stimulatory molecules such as CD40, implying that the MyD88-independent signaling pathway functions downstream of TLR4. Because these effects can also be induced by type I IFN, we have analyzed whether type I IFN is involved in TLR4-induced responses. In response to lipopolysaccharide (LPS), IFN-b gene expression was augmented in both wild-type and MyD88-de®cient BMDC. Expression of all IFNinducible genes except immune-responsive gene 1 (IRG1) was abolished and CD40 up-regulation was decreased in LPS-stimulated BMDC lacking either IFN-a/b receptor (IFN-a/bR) or signal transducer and activator of transcription 1 (STAT-1). Similar to the LPS response, TLR9 signaling can also induce expression of IFN-b and IFN-inducible genes, and up-regulation of CD40. However, all these effects were MyD88 dependent. Thus, in TLR4 signaling, IFN-b expression can be induced either by the MyD88-dependent or -independent pathway, whereas, in TLR9 signaling, it is dependent on MyD88. In CpG DNA-stimulated DC, expression of IFN-inducible genes except IRG1 was dependent on type I IFN signaling as in LPS-stimulated DC. However, in contrast to TLR4 signaling, TLR9 signaling requires type I IFN signaling for CD40 up-regulation. Taken together, this study demonstrates differential involvement of type I IFN in TLR4-and TLR9-induced effects on DC.
Introduction
Toll-like receptors (TLR) are a group of transmembrane proteins expressed mainly on antigen-presenting cells (APC) such as dendritic cells (DC) or macrophages. TLR recognize pathogen-derived products and mediate a variety of signals not only for inducing pro-in¯ammatory cytokines, but also for up-regulating co-stimulatory molecules. These effects function as immune adjuvants to establish the host defense mechanism (1) .
The mammalian TLR family consists of 10 members (2,3). They possess common intracytoplasmic regions, which are structurally similar to IL-1 receptor (IL-1R) family members. The region is called as the Toll/IL-1 receptor homology (TIR) domain and is involved in signaling pathways that are common among TLR. A cytoplasmic adapter, MyD88, associates with TLR and IL-1R through its TIR domain. Then this chain of signaling cascades can lead to activation of NF-kB or mitogen-activated protein kinases (MAPK) (4±6). MyD88-de®cient (MyD88 ±/± ) cells cannot produce any amounts of IL-12 or tumor necrosis factor (TNF)-a in response to ligands for TLR including TLR2, TLR4 and TLR9, indicating the essential roles of MyD88 in TLR-induced cytokine production (7±9).
However, TLR signaling is also differentially regulated in a TLR-speci®c manner. By analyzing MyD88 ±/± mice, TLR4 signaling was found to be unique in that it can activate the MyD88-independent signaling pathway (7) . This pathway then leads to activation of NF-kB, MAPK cascade and IFN-regulatory factor (IRF)-3 (10) , and brings about enhanced expression of a set of IFN-inducible genes (10) or DC maturation (11) . Another TIR domain containing adapter, TIRAP/Mal, is possibly involved in the pathway, because it can associate exclusively with TLR4 (12, 13) . However, it remains unknown whether TLR4 signaling directly induces these biological effects.
Type I IFN consist of >10 members of IFN-a and a single form of IFN-b, and are produced upon viral infection in a variety of cells including DC. They can activate NK cell activity, up-regulate MHC class I expression, induce cytokines or chemokines such as IFN-inducible protein 10 (IP-10) and lead to DC maturation, thereby bringing about effective antiviral defense (14) . In this study, we have evaluated how type I IFN contribute to LPS-induced effects. We have found that IFN-b, induced in a MyD88-independent manner, are involved in LPS-induced effects, including induction of the IFN-inducible genes. The genes include not only a T h 1 cell-recruiting chemokine, IP-10, gene but also glucocorticoid attenuated response gene 16 (GARG16) or immune-responsive gene 1 (IRG1) whose products have not been functionally characterized yet (15, 16) . Expression of similar sets of genes including the IFN-b gene was also enhanced through TLR9 signaling. However, unlike TLR4, all of these effects were dependent on MyD88. Thus, IFN-b is differentially involved in biological responses through TLR4 and TLR9.
Methods

Animals
C57BL/6 mice were used as wild-type mice and purchased from CLEA Japan (Tokyo, Japan). IFNa/bR ±/± mice were purchased from B & K Universal (Hull, UK) (17) . The signal transducer and activator of transcription 1 (STAT-1) ±/± mice were kindly provided by Dr Robert D. Schreiber (Washington University, St Louis, MO) (18) . MyD88 ±/± , TLR2 ±/± and TLR9 ±/± mice were described previously (19± 21) , and maintained in Osaka University mice facility. MyD88 ±/± STAT-1 ±/± mice were generated by crossing MyD88 +/± STAT-1 +/± mice.
Reagents
LPS derived from Escherichia coli O55:B5 was purchased from Sigma (St Louis, MO). Phosphorothioate-stabilized oligodeoxynucleotides containing unmethylated CpG motifs (21) were purchased from Hokkaido System Science (Sapporo, Japan). Mycoplasmal lipopeptide macrophageactivating lipopeptide-2 (MALP-2) was kindly provided by Dr P. F. Mu È hlradt (Gesellschaft fu È r Biotechnologische Forsechung, Braunscheweig, Germany) (22) . IFN-b was purchased from PBL Biomedical (New Brunswick, NJ).
Northern blot analysis
Bone marrow (BM)-derived DC were prepared according to the method of Inaba et al. (23) . BM cells were obtained from the mice and plated at 1 Q 10 6 cells/ml in 24-well plates with 10% (v/v) FCS/RPMI 1640 containing 10 ng/ml murine granulocyte macrophage colony stimulating factor (GM-CSF; Genzyme Techne, Minneapolis, MN). Every 2 days, nonadherent cells were discarded and the remaining cells were fed with fresh medium containing 10 ng/ml murine GM-CSF. At day 6, loosely adherent cells were harvested by gentle pipeting and cultured for a further 2 days. At day 8, nonadherent cells were harvested and stimulated without stimuli or with 100 ng/ml LPS, 0.1 mM CpG DNA or 30 ng/ml MALP-2 for indicated periods. Total RNA was extracted using an RNeasy kit (Qiagen, Tokyo, Japan), electrophoresed, transferred to a nylon membrane and hybridized with cDNA probes as described previously (10) .
Flow cytometric analysis
Cells were ®rst incubated with anti-CD16/32 (2.4G2; BD Biosciences, Mountain View, CA) to minimize non-speci®c binding of antibody to FcR. They were further stained with biotinylated anti-CD40 mAb (3/23; BD Biosciences) for 20 min at 4°C, washed and subsequently developed with streptavidin±phycoerythrin (BD Biosciences). Flow cytometric analysis was performed using a FACSCalibur (BD Biosciences) with CellQuest software (BD Biosciences).
EMSA
The nuclear extracts of BMDC were prepared and incubated with speci®c probes for the IFN-stimulated regulatory element (ISRE; 5¢-GATCCATGCCTCGGGAAAGGGAAACCGAAACT-GAAGCC-3¢) or NF-kB (5¢-ATCAGGGACTTTCCGCTGGGGA-CTTTCC-3¢) DNA-binding sites (7, 10) . Then the extracts were electrophoresed and visualized by autoradiography. 
Results and discussion
IFN-b induction by LPS is independent of MyD88
According to ELISA analysis, LPS could not induce either IFNa or IFN-g production from wild-type DC (data not shown). However, IFN-b gene expression was augmented in LPSstimulated wild-type DC (Figs 1 and 2 ). The induction was detected at 1 h after LPS stimulation, reached a maximum level at 2±3 h and then declined thereafter. LPS can induce IFN-b, but not IFN-a, gene expression in wild-type peritoneal macrophages (24, 25) . Thus, like macrophages, DC could enhance IFN-b, but not IFN-a, production in response to LPS.
Gene induction of cytokines including IL-6 was abolished in MyD88 ±/± DC ( Fig. 1) (7) . We have analyzed whether LPSinduced IFN-b gene expression is retained in MyD88 ±/± DC. MyD88 ±/± DC showed signi®cant, although reduced, elevation of IFN-b gene expression in response to LPS (Fig. 1) . The elevation was dependent on TLR4, because LPS-stimulated TLR4 ±/± DC showed no IFN-b gene expression (data not shown). These results indicate that IFN-b gene can be induced by TLR4 signaling in a MyD88-independent manner.
IFN-b induction is involved in TLR4-mediated up-regulation of IP-10 and GARG16 genes
As in MyD88 ±/± macrophages (10), MyD88 ±/± DC manifested up-regulation of IFN-inducible genes including IP-10 and GARG16 in response to LPS (Fig. 1) . Furthermore, IRG1 gene expression was also enhanced in MyD88 ±/± DC. The IRG1 gene, originally identi®ed as a LPS-inducible gene (16) , was also up-regulated by IFN-b (data not shown).
We have next examined whether expression of these genes by LPS is enhanced directly through TLR4 signaling or secondarily induced through the function of IFN-b. Type I IFN, IFN-a and IFN-b, bind to their common receptor, IFN-a/ bR. Deletion of IFN-a/bR can lead to refractoriness to type I IFN (17) . Therefore, we have analyzed effects of LPS on IFN-a/ bR ±/± DC. LPS could induce expression not only of IL-6 or TNFa (data not shown), but also of IFN-b in IFN-a/bR ±/± DC. However, the mutant DC could not enhance expression of IP-10 or GARG16 in response to LPS (Fig. 1) .
STAT-1 is a critical signal transducer for type I IFN (18) . Similar to IFN-a/bR ±/± DC, STAT-1 ±/± DC retained LPS-induced up-regulation of IFN-b or other cytokine genes, but did not manifest any increased expression of IP-10 or GARG16 (Fig. 1) . These results indicate that IFN-b signaling is essential for the TLR4-induced up-regulation of IP-10 and GARG16 genes. As type I IFN signaling activates expression of the target gene through the ISRE site (26), our results are consistent with the previous ®nding that the ISRE site in the IP-10 gene promoter is essential for LPS-induced IP-10 gene expression (27) .
TLR4 signaling can induce IRG1 gene expression in a MyD88-and IFN-b-independent manner
In contrast to IP-10 and GARG16 genes, the IRG1 gene (16) was induced in LPS-stimulated IFN-a/bR ±/± and STAT-1 ±/± DC (Fig. 1) , indicating that IRG1 gene induction through TLR4 signaling is independent of IFN-b signaling. Toshchakov et al. described that IP-10 and MCP-5 genes are up-regulated in LPS-stimulated macrophages in an IFN-b-dependent manner (28) . Thus, IRG1 gene expression is regulated distinctly from other IFN-inducible genes.
Kinetic analysis of the gene expression also supports differential involvement of IFN-b in the expression of IFNinducible genes. IP-10 and GARG16 expression reached a peak at 4 h after addition of LPS, whereas IFN-b and IRG1 expression was already enhanced within 1 h. Thus, both IFN-b and IRG1 genes is considered to be directly induced by TLR4 signaling. However, their regulatory mechanism is clearly different. Notably, IFN-b gene expression by LPS was slightly impaired in MyD88 ±/± or STAT-1 ±/± DC and severely decreased in MyD88 ±/± STAT-1 ±/± DC (Fig. 1) , indicating that IFN-b gene induction requires either the MyD88-dependent pathway or positive feedback mechanism by IFN-b itself. In contrast, IRG1 gene induction by LPS was unaltered in MyD88 ±/± , STAT-1 ±/± and MyD88 ±/± STAT-1 ±/± DC, indicating that IRG1 gene expression is independent of MyD88 and IFN-b signaling. At present, little is known how IRG1 gene expression is regulated. Further studies are necessary to clarify how TLR4 signaling activates IRG1 expression. (Fig. 2) . The results are in accordance with the involvement of IFN-b in mediating up-regulation of IFNinducible genes.
We have next tested effects of a TLR9 ligand, CpG DNA, on DC. CpG DNA in this and a previous study (21) could not induce IFN-a production (data not shown), but could induce IFN-b gene up-regulation (Figs 2 and 3) . The peak of the expression levels was reached at 4±6 h after stimulation. This induction kinetics is delayed compared with that of TLR4 signaling (Figs 1 and 3) . Unlike TLR4 signaling, TLR9 signaling could not induce IFN-b gene expression in MyD88 ±/± DC. Thus, CpG DNA can induce IFN-b gene expression in a MyD88-dependent manner. 
Critical roles of IFN-b in TLR9-mediated augmentation of IFN-inducible genes
We have analyzed expression of IFN-inducible genes, IP-10, GARG16 and IRG1, in CpG DNA-stimulated DC. As in LPSstimulated wild-type DC, expression of these genes was also augmented in CpG DNA-stimulated wild-type DC (Fig. 3) . Expression of all of these genes as well as the IFN-b gene was almost abolished in MyD88 ±/± DC. In order to assess whether IFN-b contributes to CpG DNA-induced up-regulation of IFNinducible genes, we have investigated effects of CpG DNA on IFN-a/bR ±/± DC (Fig. 3) . In response to CpG DNA, the mutant DC The IFN-b promoter carries two critical cis-acting elements, NF-kB and ISRE sites, both of which are essential for IFN-b gene expression upon viral infection (29±32). We have analyzed whether CpG DNA can induce DNA binding activities to NF-kB or ISRE sites in CpG DNA-stimulated MyD88 ±/± DC (Fig. 4) . In response to CpG DNA, both binding activities were induced in wild-type DC. However, these activities were not observed at all in CpG DNA-stimulated MyD88 ±/± DC. Meanwhile, MyD88 ±/± DC increased their DNA binding activities to NF-kB and ISRE (data not shown) sites in response to LPS (Fig. 4) (7) . Thus, NF-kB and ISRE site binding activities induced by TLR9 signaling were dependent on MyD88.
TLR-induced regulation of CD40 expression
TLR4 signaling can augment surface expression of CD40 in a MyD88-independent manner (11) . Therefore, we have further investigated whether IFN-b is also involved in CD40 upregulation. IFN-b could enhance CD40 expression of both wild-type and MyD88 ±/± DC (Fig. 5) . As expected, IFN-b could not up-regulate CD40 in either IFN-a/bR ±/± or STAT-1 ±/± DC.
When stimulated with LPS, IFN-a/bR ±/± DC showed increased expression of CD40 (Fig. 6A) . However, the expression level was lower than that of LPS-stimulated wild-type DC. In addition, STAT-1 ±/± DC and MyD88 ±/± DC also showed reduced levels of CD40 expression in response to LPS (Fig. 6B) . Notably, the expression of CD40 was further Fig. 4 . EMSA of the nuclear extract from LPS or CpG DNAstimulated DC. BMDC from wild-type and MyD88 ±/± mice were stimulated with 1 mg/ml LPS or 1 mM CpG DNA for the indicated periods. NF-kB or ISRE DNA binding activity in the nuclear extract was analyzed by EMSA. decreased in MyD88 ±/± STAT-1 ±/± DC. Thus, optimal CD40 induction by LPS requires both MyD88 and IFN-b signaling.
Next, we have assessed involvement of IFN-b in CpG DNAinduced CD40 up-regulation. CpG DNA can induce CD40 expression on DC in a TLR9-dependent manner (Fig. 6D ). IFNa/bR ±/± DC showed detectable, but diminished, up-regulation of CD40 in response to CpG DNA (Fig. 6C) . In addition, STAT-1 ±/± DC also manifested severely reduced expression of CD40 in response to CpG DNA (Fig. 6D) . Thus, IFN-b and its signaling are thought to be crucially involved in CpG DNAinduced CD40 up-regulation.
In this study, we have analyzed how IFN-b is involved in TLR-mediated effects on DC. TLR4 signaling can activate MyD88 ±/± DC to express a set of IFN-inducible genes. Mutant DC with defective type I IFN signaling have lost their expression (Fig. 1) . Furthermore, the IFN-b gene can be induced by LPS in a MyD88-independent manner (Fig. 1) . Therefore, it can be reasonably assumed that IFN-b is responsible for LPS-induced expression of IFN-inducible genes. It is also noteworthy that IRG1 is unique among IFNinducible genes in that its gene induction by TLR4 is independent of type I IFN. Thus, IFN-b and IRG1 are direct (Fig. 6A±D) . Thus, IFN-b is differentially involved in TLR4-and TLR9-induced CD40 up-regulation. Broken lines indicate the MyD88-independent pathway in TLR4 signaling.
targets of the TLR4-mediated MyD88-independent pathway (Fig. 7A) . IRF-3 activation, required for IFN-b gene expression (26, 33) , seems to be located along the pathway. However, it remains unknown how TLR4 signaling can lead to IRF3 activation. Another TLR4 adapter, TIRAP/Mal, is possibly involved in it, but further studies are necessary to clarify the MyD88-independent signaling pathway.
TLR9 signaling can induce similar sets of type I IFNinducible genes to those induced by TLR4 signaling (Fig. 3) . TLR9 signaling can induce IFN-b in a MyD88-dependent manner, and IFN-b and its signaling are responsible for the expression of IFN-inducible genes such as IP-10 or GARG16 (Fig. 7A) . It remains unknown how TLR9 signaling can activate IFN-b gene expression without activating the MyD88-independent pathway. Taken together, IFN-b, induced in an either MyD88-independent or -dependent manner, is critically involved in enhanced expression of IFN-inducible genes through TLR4 or TLR9 (Fig. 7A) .
LPS can induce DC maturation without MyD88, characterized by up-regulation of surface CD40 expression (11) . Mutant DC with defective type I IFN signaling showed reduced levels of CD40 expression in response to LPS, indicating the involvement of type I IFN on CD40 up-regulation. LPSstimulated MyD88 ±/± DC also exhibited slightly decreased expression of CD40 as compared with LPS-stimulated wildtype DC. Thus, MyD88-dependent and IFN-b-induced effects coordinately contribute to optimal CD40 induction by LPS (Fig. 7B) . In contrast, TLR9-mediated CD40 up-regulation is largely dependent on type I IFN production (Figs 6C and D, and 7B). Thus, in terms of CD40 up-regulation, type I IFN is more critical in TLR9-than in TLR4-mediated effects on BMDC.
Type I IFN can be induced by not only viral but also bacterial infection (34) . Because this phenomenon can be attributed to TLR signaling, it should be critical for manipulating host defense mechanisms to make it clear how TLR induce type I IFN production and how type I IFN is involved in TLR-induced biological effects. The present study can provide critical information for this goal. 
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